Light Mode
$6.21 ↑ +0.11 (+1.87%) Trading Up from the previous close of $6.10, and at the day’s high of $6.21
+0.27 (+4.70%) / 6M
Momentum, market sentiment, and recent alerts
EKTAY reads n/a: price sits above both the 20- and 200-day averages, the 12-month move is +26.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: Americas, EMEA, APAC, and Others. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.